MIT's Barzilay and Collins Win Pritzker Prize for AI-Enabled Antibiotic Discovery

Summary

Professors Regina Barzilay and Jim Collins from MIT received the 2026 Pritzker Prize for Excellence in Scientific Research. The award honors their discovery of halicin, the first antibiotic identified by a deep learning model in 2020, and abaucin, a narrower-spectrum antibiotic discovered in 2023.

Why it matters

Antimicrobial resistance is one of the greatest threats to global health. Demonstrating that AI can reduce the time to identify candidate chemicals from years to weeks offers a reliable path to accelerating antibiotic development pipelines. The award also institutionally confirms that AI-assisted molecular discovery has evolved from a novelty into a recognized field of research. This endorsement is reinforced by the support of institutions such as the University of Chicago and Caltech.

Highlights

• Halicin was not a molecule designed from scratch. It was a repurposed diabetes compound flagged by a model trained on only about 2,500 molecules.
• Abaucin's narrow-spectrum profile against A. baumannii holds strategic value for limiting side-effect resistance and damage to the gut microbiota.
• Barzilay warns that AI currently automates only certain parts of the drug discovery pipeline. She also notes that realistic models of human biology are still lacking.

Critical take

The phrase "first AI-discovered antibiotic" exaggerates the novelty. Halicin was a known compound re-screened by a small model. The article is essentially an award press release. It provides no updates on whether either candidate has progressed beyond in-vitro testing to clinical trials. Barzilay's measured statement that "we are still in the early stages" is the most honest sentence in the text. This remark casts a shadow over the celebratory tone.